AF
PLRX icon

Amalgamated Financial’s Pliant Therapeutics PLRX Stock Holding History

Amalgamated Financial’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$27K Buy
+3,844
New +$39.2K ﹤0.01% 2653

Other funds holding PLRX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Amalgamated Financial's PLRX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Pliant Therapeutics (PLRX) in Q1 2022: 3,844 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #2653 among its holdings.

92 funds tracked by Wall St. Rank hold PLRX as of Q1 2022.

  • Amalgamated Financial held 3,844 shares of Pliant Therapeutics worth $27K as of Q1 2022.
  • Pliant Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • Pliant Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2653 holding.
  • 92 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.